{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:08:30Z","timestamp":1792451310352,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2024,12,28]]},"DOI":"10.1038\/s41416-024-02880-8","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T06:03:34Z","timestamp":1730786614000},"page":"1928-1941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Low-dose arsenic trioxide inhibits pancreatic stellate cell activation via LOXL3 expression to enhance immunotherapy in pancreatic cancer"],"prefix":"10.1038","volume":"131","author":[{"given":"Yue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tairan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoda","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1501-740X","authenticated-orcid":false,"given":"Yuzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2880_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22708","volume":"35","author":"K Mortezaee","year":"2021","unstructured":"Mortezaee K. Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer. J Biochem Mol Toxicol. 2021;35:e22708.","journal-title":"J Biochem Mol Toxicol"},{"key":"2880_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ctrv.2019.06.005","volume":"78","author":"A Henriksen","year":"2019","unstructured":"Henriksen A, Dyhl-Polk A, Chen I, Nielsen D. Checkpoint inhibitors in pancreatic cancer. Cancer Treat Rev. 2019;78:17\u201330.","journal-title":"Cancer Treat Rev"},{"key":"2880_CR3","doi-asserted-by":"publisher","first-page":"108707","DOI":"10.1016\/j.clim.2021.108707","volume":"226","author":"J Majidpoor","year":"2021","unstructured":"Majidpoor J, Mortezaee K. The efficacy of PD-1\/PD-L1 blockade in cold cancers and future perspectives. Clin Immunol. 2021;226:108707.","journal-title":"Clin Immunol"},{"key":"2880_CR4","doi-asserted-by":"crossref","unstructured":"Nilsson M, Adamo H, Bergh A, & Halin Bergstr\u00f6m S. Inhibition of lysyl oxidase and lysyl oxidase-like enzymes has tumour-promoting and tumour-suppressing roles in experimental prostate cancer. Sci Rep. 2016;6:19608.","DOI":"10.1038\/srep19608"},{"key":"2880_CR5","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pages","year":"2018","unstructured":"Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128\u201339.","journal-title":"Lancet"},{"key":"2880_CR6","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1158\/1078-0432.CCR-19-1090","volume":"25","author":"T Doi","year":"2019","unstructured":"Doi T, Muro K, Ishii H, Kato T, Tsushima T, Takenoyama M, et al. A phase I study of the anti-CC chemokine receptor 4 antibody, mogamulizumab, in combination with nivolumab in patients with advanced or metastatic solid tumors. Clin Cancer Res. 2019;25:6614\u201322.","journal-title":"Clin Cancer Res"},{"key":"2880_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/annonc\/mdz113","volume":"30","author":"MD Hellmann","year":"2019","unstructured":"Hellmann MD, Kim TW, Lee CB, Goh BC, Miller WH, Oh DY, et al. Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors. Ann Oncol. 2019;30:1134\u201342.","journal-title":"Ann Oncol"},{"key":"2880_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","volume":"339","author":"SL Soignet","year":"1998","unstructured":"Soignet SL, Maslak P, Wang Z-G, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998;339:1341\u20138.","journal-title":"N Engl J Med"},{"key":"2880_CR9","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1016\/j.biomaterials.2013.04.056","volume":"34","author":"C Qian","year":"2013","unstructured":"Qian C, Wang Y, Chen Y, Zeng L, Zhang Q, Shuai X, et al. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles. Biomaterials. 2013;34:6175\u201384.","journal-title":"Biomaterials"},{"key":"2880_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41423-022-00956-0","volume":"20","author":"J Chen","year":"2023","unstructured":"Chen J, Jin Z, Zhang S, Zhang X, Li P, Yang H, et al. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis. Cell Mol Immunol. 2023;20:51\u201364.","journal-title":"Cell Mol Immunol"},{"key":"2880_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/abbs\/gmw022","volume":"48","author":"Z Chen","year":"2016","unstructured":"Chen Z, Zhang H, Yang L, Jiang H, Guo S, Li Y, et al. Construction of a metabolomics profile of arsenic trioxide effect in gastric carcinoma cell line SGC7901. Acta Biochim Biophys Sin. 2016;48:474\u201381.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2880_CR12","doi-asserted-by":"publisher","first-page":"90905","DOI":"10.18632\/oncotarget.18677","volume":"8","author":"X Duan","year":"2017","unstructured":"Duan X, Li T, Han X, Ren J, Chen P, Li H, et al. The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide. Oncotarget. 2017;8:90905\u201315.","journal-title":"Oncotarget"},{"key":"2880_CR13","first-page":"991","volume":"11","author":"J Gao","year":"2019","unstructured":"Gao J, Wang G, Wu J, Zuo Y, Zhang J, Chen J. Arsenic trioxide inhibits Skp2 expression to increase chemosensitivity to gemcitabine in pancreatic cancer cells. Am J Transl Res. 2019;11:991\u20137.","journal-title":"Am J Transl Res"},{"key":"2880_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1039\/c9mt00308h","volume":"12","author":"QQ Wang","year":"2020","unstructured":"Wang QQ, Jiang Y, Naranmandura H. Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases. Metallomics. 2020;12:326\u201336.","journal-title":"Metallomics"},{"key":"2880_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1465-9921-15-51","volume":"15","author":"F Luo","year":"2014","unstructured":"Luo F, Zhuang Y, Sides MD, Sanchez CG, Shan B, White ES, et al. Arsenic trioxide inhibits transforming growth factor-\u03b21-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. Respir Res. 2014;15:51.","journal-title":"Respir Res"},{"key":"2880_CR16","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1039\/D2BM01039A","volume":"10","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Yao H, Yang K, Han S, Chen S, Li Y, et al. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal of pancreatic stellate cell desmoplasia by targeting the AP4\/galectin-1 pathway. Biomater Sci. 2022;10:5989\u20136002.","journal-title":"Biomater Sci"},{"key":"2880_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.pan.2020.01.003","volume":"20","author":"SP Pothula","year":"2020","unstructured":"Pothula SP, Pirola RC, Wilson JS, Apte MV. Pancreatic stellate cells: aiding and abetting pancreatic cancer progression. Pancreatology. 2020;20:409\u201318.","journal-title":"Pancreatology"},{"key":"2880_CR18","doi-asserted-by":"crossref","unstructured":"Laurentino TS, Soares RDS, Marie SK N & Oba-Shinjo SM. LOXL3 function beyond amino oxidase and role in pathologies, including cancer. Int J Mol Sci. 2019;20:3587.","DOI":"10.3390\/ijms20143587"},{"key":"2880_CR19","doi-asserted-by":"publisher","unstructured":"Wang, N., Zhou, X., Tang, F., Wang, X. & Zhu, X. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma. Virchows Archiv Int J Pathol https:\/\/doi.org\/10.1007\/s00428-021-03193-4 (2021).","DOI":"10.1007\/s00428-021-03193-4"},{"key":"2880_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/s41418-017-0030-2","volume":"25","author":"PG Santamar\u00eda","year":"2018","unstructured":"Santamar\u00eda PG, Florist\u00e1n A, Fontanals-Cirera B, V\u00e1zquez-Naharro A, Santos V, Morales S, et al. Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability. Cell Death Differ. 2018;25:935\u201350.","journal-title":"Cell Death Differ"},{"key":"2880_CR21","doi-asserted-by":"crossref","unstructured":"Weniger M, Honselmann KC, & Liss AS. The extracellular matrix and pancreatic cancer: a complex relationship. Cancers. 2018;10:316.","DOI":"10.3390\/cancers10090316"},{"key":"2880_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1053\/j.gastro.2016.03.040","volume":"150","author":"CC DuFort","year":"2016","unstructured":"DuFort CC, DelGiorno KE, Hingorani SR. Mounting pressure in the microenvironment: fluids, solids, and cells in pancreatic ductal adenocarcinoma. Gastroenterology. 2016;150:1545\u20131557.e1542.","journal-title":"Gastroenterology"},{"key":"2880_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","volume":"11","author":"R Francescone","year":"2021","unstructured":"Francescone R, Barbosa Vendramini-Costa D, Franco-Barraza J, Wagner J, Muir A, Lau AN, et al. Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression. Cancer Discov. 2021;11:446\u201379.","journal-title":"Cancer Discov"},{"key":"2880_CR24","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.7150\/thno.43631","volume":"10","author":"D Wu","year":"2020","unstructured":"Wu D, Zhu ZQ, Tang HX, Shi ZE, Kang J, Liu Q, et al. Efficacy-shaping nanomedicine by loading calcium peroxide into tumor microenvironment-responsive nanoparticles for the antitumor therapy of prostate cancer. Theranostics. 2020;10:9808\u201329.","journal-title":"Theranostics"},{"key":"2880_CR25","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1039\/C6TB00734A","volume":"4","author":"Y Shao","year":"2016","unstructured":"Shao Y, Wang L, Fu J, Shi C, Xu J, Zhu Y. Efficient free radical generation against cancer cells by low-dose X-ray irradiation with a functional SPC delivery nanosystem. J Mater Chem B. 2016;4:5863\u201372.","journal-title":"J Mater Chem B"},{"key":"2880_CR26","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.3892\/mmr.2015.3259","volume":"11","author":"D Patsouras","year":"2015","unstructured":"Patsouras D, Papaxoinis K, Kostakis A, Safioleas MC, Lazaris AC, Nicolopoulou-Stamati P. Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma. Mol Med Rep. 2015;11:4585\u201390.","journal-title":"Mol Med Rep"},{"key":"2880_CR27","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.3390\/cancers14184351","volume":"14","author":"K Yamamoto","year":"2022","unstructured":"Yamamoto K, Iwadate D, Kato H, Nakai Y, Tateishi K, Fujishiro M. Targeting the metabolic rewiring in pancreatic cancer and its tumor microenvironment. Cancers. 2022;14:4351.","journal-title":"Cancers"},{"key":"2880_CR28","doi-asserted-by":"crossref","unstructured":"Kalim KW, Yang JQ, Wunderlich M, Modur V, Nguyen P, Li Y, et al. Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity. J Immunother Cancer. 2022;10:e004806.","DOI":"10.1136\/jitc-2022-004806"},{"key":"2880_CR29","doi-asserted-by":"crossref","unstructured":"LaRue MM, Parker S, Puccini J, Cammer M, Kimmelman AC, & Bar-Sagi D. Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer. Proc Natl Acad Sci. 2022;119:e2119168119.","DOI":"10.1073\/pnas.2119168119"},{"key":"2880_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18298-8","volume":"11","author":"DH Peng","year":"2020","unstructured":"Peng DH, Rodriguez BL, Diao L, Chen L, Wang J, Byers LA, et al. Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion. Nat Commun. 2020;11:4520.","journal-title":"Nat Commun"},{"key":"2880_CR31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia CJ, Huang Y, Fuentes NR, Turner MC, Monberg ME, Lin D, et al. Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment. Gastroenterology. 2022;162:2018\u201331.","journal-title":"Gastroenterology"},{"key":"2880_CR32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s43018-021-00326-1","volume":"3","author":"C Falcomat\u00e0","year":"2022","unstructured":"Falcomat\u00e0 C, B\u00e4rthel S, Widholz SA, Schneeweis C, Montero JJ, Toska A, et al. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nat Cancer. 2022;3:318\u201336.","journal-title":"Nat Cancer"},{"key":"2880_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/antiox11040689","volume":"11","author":"S-H Ro","year":"2022","unstructured":"Ro S-H, Bae J, Jang Y, Myers JF, Chung S, Yu J, et al. Arsenic toxicity on metabolism and autophagy in adipose and muscle tissues. Antioxidants. 2022;11:689.","journal-title":"Antioxidants"},{"key":"2880_CR34","doi-asserted-by":"publisher","first-page":"23905","DOI":"10.18632\/oncotarget.14733","volume":"8","author":"I Khairul","year":"2017","unstructured":"Khairul I, Wang QQ, Jiang YH, Wang C, Naranmandura H. Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget. 2017;8:23905\u201326.","journal-title":"Oncotarget"},{"key":"2880_CR35","first-page":"66","volume":"255","author":"Z Tian","year":"2023","unstructured":"Tian Z, Tan Y, Lin X, Su M, Pan L, Lin L, et al. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1\/PI3K\/AKT\/mTOR axis. Transl Res J Lab Clin Med. 2023;255:66\u201376.","journal-title":"Transl Res J Lab Clin Med"},{"key":"2880_CR36","doi-asserted-by":"publisher","first-page":"73529","DOI":"10.18632\/oncotarget.19867","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li C, Zheng Y, Lin Z, Zhang Y, Zhang Z. Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-\u03b21-CTGF-VEGF functional module in rheumatoid arthritis. Oncotarget. 2017;8:73529\u201346.","journal-title":"Oncotarget"},{"key":"2880_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17:487\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2880_CR38","doi-asserted-by":"publisher","first-page":"117049","DOI":"10.1016\/j.lfs.2019.117049","volume":"239","author":"M Najafi","year":"2019","unstructured":"Najafi M, Mortezaee K, Majidpoor J. Stromal reprogramming: a target for tumor therapy. Life Sci. 2019;239:117049.","journal-title":"Life Sci"},{"key":"2880_CR39","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/jcb.27703","volume":"120","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. Cancer-associated fibroblasts: secretions, interactions, and therapy. J Cell Biochem. 2019;120:2791\u20132800.","journal-title":"J Cell Biochem"},{"key":"2880_CR40","doi-asserted-by":"crossref","unstructured":"Fejza A, Polano M, Camicia L, Poletto E, Carobolante G, Toffoli G, et al. The efficacy of Anti-PD-L1 treatment in melanoma is associated with the expression of the ECM molecule EMILIN2. Int J Mol Sci. 2021;22:7511.","DOI":"10.3390\/ijms22147511"},{"key":"2880_CR41","doi-asserted-by":"crossref","unstructured":"Kuczek DE, Larsen AMH, Thorseth M-L, Carretta M, Kalvisa A, Siersb\u00e6k MS, et al. Collagen density regulates the activity of tumor-infiltrating T cells. J ImmunoTher Cancer 2019;7:68.","DOI":"10.1186\/s40425-019-0556-6"},{"key":"2880_CR42","doi-asserted-by":"crossref","unstructured":"Jiang C, Wang M, Yao W, Lv G, Liu X, & Wang G. Comprehensive analysis on prognosis and immune infiltration of lysyl oxidase family members in pancreatic adenocarcinoma with experimental verification. Front Mol Biosci. 2022;9:778857.","DOI":"10.3389\/fmolb.2022.778857"},{"key":"2880_CR43","doi-asserted-by":"crossref","unstructured":"Ferrara B, Pignatelli C, Cossutta M, Citro A, Courty J, & Piemonti L. The extracellular matrix in pancreatic cancer: description of a complex network and promising therapeutic options. Cancers. 2021;13:4442.","DOI":"10.3390\/cancers13174442"},{"key":"2880_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molcel.2016.12.002","volume":"65","author":"L Ma","year":"2017","unstructured":"Ma L, Huang C, Wang X-J, Xin DE, Wang L-S, Zou QC, et al. Lysyl Oxidase 3 is a dual-specificity enzyme involved in STAT3 deacetylation and deacetylimination modulation. Mol Cell. 2017;65:296\u2013309.","journal-title":"Mol Cell"},{"key":"2880_CR45","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/adma.201104763","volume":"24","author":"F Tang","year":"2012","unstructured":"Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24:1504\u201334.","journal-title":"Adv Mater"},{"key":"2880_CR46","doi-asserted-by":"crossref","unstructured":"Kawase T, Yasui Y, Nishina S, Hara Y, Yanatori I, Tomiyama Y, et al. Fibroblast activation protein-\u03b1-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. BMC Gastroenterol. 2015;15:109.","DOI":"10.1186\/s12876-015-0340-0"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02880-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02880-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02880-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T12:02:59Z","timestamp":1733745779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02880-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,28]]}},"alternative-id":["2880"],"URL":"https:\/\/doi.org\/10.1038\/s41416-024-02880-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of human samples was approved by Sun Yat-sen Memorial Hospital Ethics Committee and the informed consent from all participants were obtained (SYSKY-2023-116-01). All methods involved in this study were carried out in accordance with relevant guidelines and regulations. All animals care and experimental procedures were conducted according to the National Research Council\u2019s Guidelines for the Care and Use of Laboratory Animals, and were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University Cancer Center (L102012022040E).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}